← Eichor
Study identifier: NCT07552805 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care.

Condition: Reduction in the Initial Length of Stay  ·  Sponsor: Rhythm Diagnostic Systems

PhaseNA
Planned participants490
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The SENSE-ECO study is a prospective, randomized trial of 490 high-risk patients designed to show that the MultiSense® remote monitoring patch safely reduces hospital stays following major digestive surgery. By continuously tracking vital signs for five days at home, the device aims to maintain clinical safety and quality of life while decreasing overall healthcare costs for the French medical system.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (5)

CHU de NiceNice, Alpes-Maritimes, FranceNot Yet Recruiting
CHU de BesançonBesançon, Doubs, FranceNot Yet Recruiting
CHU Charles-NicolleRouen, Seine-Maritime, FranceNot Yet Recruiting
CHU Amiens-PicardieAmiens, FranceNot Yet Recruiting
Hôpital Cochin, AP-HP CentreParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07552805